Prestige Consumer Healthcare
PBH
#4619
Rank
NZ$3.87 B
Marketcap
NZ$81.74
Share price
-0.48%
Change (1 day)
-42.94%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): NZ$6.93

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$6.86. In 2024 the company made an earnings per share (EPS) of NZ$7.32 an increase over its 2023 EPS that were of NZ-$2.74.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.93-5.32%
2024NZ$7.32-367.08%
2023NZ-$2.74-138.33%
2022NZ$7.1511.7%
2021NZ$6.4013.6%
2020NZ$5.64-651.67%
2019NZ-$1.02-148.78%
2018NZ$2.09-83.29%
2017NZ$12.53437.23%
2016NZ$2.33-34.13%
2015NZ$3.5452.94%
2014NZ$2.32-8.11%
2013NZ$2.52
2011NZ$1.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.88 116.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$11.90 73.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.95 74.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.23-67.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.15-10.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$10.52 53.35%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$3.93-42.68%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.62-3.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
NZ-$50.44-834.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.08-69.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel